X
<

Dentsply Sirona: Its Partnerships and Collaborations

PART:
1 2 3 4 5
Part 5
Dentsply Sirona: Its Partnerships and Collaborations PART 5 OF 5

Dentsply Sirona Stock Recovering from Recent 52-Week Low

Stock performance

Dentsply Sirona (XRAY) closed at $57.81 on September 21, 2017. The company reported its 52-week high of $65.68 on May 8, 2017. However, the company was trading at its 52-week low of $52.53 on August 21, 2017. The stock has recovered since. In the past one month, XRAY stock has risen 9.5%. XRAY investors in the past three months have witnessed the company’s stock fall 9.4%.

Dentsply Sirona Stock Recovering from Recent 52-Week Low

Interested in ALGN? Don't miss the next report.

Receive e-mail alerts for new research on ALGN

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.

Dentsply Sirona has a 50-day moving average of $62.88 and a 200-day moving average of $62.38. Year-to-date, the stock has risen 0.14%. The company was witnessing a bearish trend but is now recovering from the losses.

Dentsply Sirona reported its 2Q17 earnings on August 9, 2017. It reported disappointing sales and earnings and reduced its 2017 guidance. Following the announcement, XRAY stock fell ~8.4% that day. Weak investor sentiments led to a further fall in the company’s stock in August with the stock reporting its 52-week low on August 21, 2017. In the near term, XRAY’s strong fundamentals and leading market position are expected to lead the long-term growth for the stock.

Industry comparison

In the last 12 months, Dentsply Sirona has returned -3.5%. In comparison, the S&P 500, which represents the market, rose ~16.9% in the last year. In the same period, the US healthcare sector, represented by the Health Care Select Sector SPDR ETF (XLV) rose 13.1%.

On September 21, 2017, Zimmer Biomet Holdings (ZBH), Integra LifeSciences (IART), and Align Technology (ALGN) returned -9.0%, 12.2%, and 98.5%, respectively, over the past year.

X

Please select a profession that best describes you: